Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis.

Cell Rep Med · 2021 · PMC8484502 · PMID 34622226

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

did not reach statistical significancep = 0.088so close (0.05 < p ≤ 0.1)

Liver metastasis was found more frequently in high- Fusobacterium patients than in low- Fusobacterium patients, but the difference did not reach statistical significance (85.7% versus 54.5%; p = 0.088; Table S4 ; Figure S4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.